What are the major opportunities in the Lyme Disease Testing market? What are the strategies for the Lyme Disease Testing market?

For detailed insights on the major opportunities and strategies in the Lyme Disease Testing market, Read More

How does the Lyme Disease Testing market relate to the overall economy and other similar markets?

For detailed insights on Lyme Disease Testing's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Lyme Disease Testing market growth? SWOT analysis of the Lyme Disease Testing market.

For detailed insights on the key dynamics influencing the Lyme Disease Testing market growth and SWOT analysis of the Lyme Disease Testing industry, Read More

Global Lyme Disease Testing Market Report 2025

Item added to cart!

Published : December 2025

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00 $3367.00

Purchase This Report Download Sample PDF

Purchase This Report

Lyme Disease Testing Global Market Report 2025

Name: Lyme Disease Testing Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Test Type (Serological Tests, Nucleic Acid Tests, Urine Antigen Tests, Other Test Types), By Testing Methodology (Enzyme-Linked Immunosorbent Assay (ELISA), Weste Blot, Polymerase Chain Reaction (PCR), Immunofluorescence Assay (IFA), Other Emerging Technologies), By Disease Stage (Early Lyme Disease, Disseminated Lyme Disease, Chronic Lyme Disease, Asymptomatic Lyme Disease Detection), By Sample Type (Blood, Urine, Cerebrospinal Fluid(CSF), Other Blood Samples), By End-User (Hospitals And Clinics, Diagnostic Laboratories, Home Care Settings, Research Institutions, Public Health Organizations) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Lyme Disease Testing Market Overview

• Lyme Disease Testing market size has reached to $9.77 billion in 2024

• Expected to grow to $15.11 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%

• Growth Driver: Rising Prevalence Of Tick-Borne Illnesses Fueling The Need For Early Detection And Diagnosis

• Market Trend: Technological Advancements In Diagnostic Tools For Enhanced Accuracy And Early Detection Capabilities

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Lyme Disease Testing Market?

Lyme disease testing refers to diagnostic procedures used to detect infection with Borrelia burgdorferi, the bacteria responsible for Lyme disease, typically transmitted through tick bites. The primary purpose of lyme disease testing is to accurately diagnose the infection, especially in individuals showing symptoms such as fever, fatigue, and the characteristic bull's-eye rash.

The main test types involved in lyme disease testing include serological tests, nucleic acid tests, urine antigen tests, and others. Serological tests are diagnostic procedures that detect antibodies or antigens in a person’s blood to determine exposure to infections or immune responses. Various testing methodologies comprise enzyme-linked immunosorbent assay (ELISA), Western blot, polymerase chain reaction (PCR), immunofluorescence assay (IFA), and others. Different disease stages include early Lyme disease, disseminated Lyme disease, chronic Lyme disease, and asymptomatic Lyme disease detection. The different sample types used for testing include blood, urine, cerebrospinal fluid (CSF), and others. These tests are utilized by various end-users, such as hospitals and clinics, diagnostic laboratories, home care settings, research institutions, and public health organizations.

Lyme Disease Testing Market Size and growth rate 2025 to 2029: Graph

What Is The Lyme Disease Testing Market Size 2025 And Growth Rate?

The lyme disease testing market size has grown strongly in recent years. It will grow from $9.77 billion in 2024 to $10.68 billion in 2025 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to increasing demand for early disease detection, growing availability of advanced diagnostic tools, rising incidence of tick populations due to climate change, increasing government funding for vector-borne disease control, and growing healthcare infrastructure in rural and endemic areas.

What Is The Lyme Disease Testing Market Growth Forecast?

The lyme disease testing market size is expected to see strong growth in the next few years. It will grow to $15.11 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to increasing travel to endemic regions, increasing use of multiplex diagnostic technologies, a rising number of outdoor recreational activities, growing demand for home-based testing kits, and rising concerns over co-infections with other tick-borne diseases. Major trends in the forecast period include advancements in molecular diagnostic techniques, advancements in biomarker research, technology innovation in point-of-care testing devices, developments in lab-on-a-chip (microfluidic) technology, and advancements in immunoassay technologies.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Medical Equipment Industry?

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

How Is The Lyme Disease Testing Market Segmented?

1) By Test Type: Serological Tests, Nucleic Acid Tests, Urine Antigen Tests, Other Test Types

2) By Testing Methodology: Enzyme-Linked Immunosorbent Assay (ELISA), Weste Blot, Polymerase Chain Reaction (PCR), Immunofluorescence Assay (IFA), Other Emerging Technologies

3) By Disease Stage: Early Lyme Disease, Disseminated Lyme Disease, Chronic Lyme Disease, Asymptomatic Lyme Disease Detection

4) By Sample Type: Blood, Urine, Cerebrospinal Fluid(CSF), Other Blood Samples

5) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Home Care Settings, Research Institutions, Public Health Organizations

Subsegments:

1) By Serological Tests: Enzyme-Linked Immunosorbent Assay, Western Blot, Immunofluorescence Assay (IFA), Line Immunoassay (LIA)

2) By Nucleic Acid Tests: Polymerase Chain Reaction (PCR), Loop-Mediated Isothermal Amplification (LAMP), Next-Generation Sequencing (NGS)

3) By Urine Antigen Tests: Lateral Flow Assay, Enzyme Immunoassay (EIA), Immunoblot Urine Tests

4) By Other Test Types: Culture-Based Tests, Tick-Borne Co-Infection Panels, Artificial Intelligence-Assisted Diagnostic Tools

What Is Driving The Lyme Disease Testing Market? Rising Prevalence Of Tick-Borne Illnesses Fueling The Need For Early Detection And Diagnosis

The rising prevalence of tick-borne illnesses is expected to propel the growth of the lyme disease testing market going forward. Tick-borne illnesses refer to a group of diseases that are transmitted to humans through the bite of infected ticks, which are small, blood-feeding parasites found in grassy, wooded, or rural areas. The rising demand for tick-borne illness treatments is fueled by the expanding geographic range of ticks caused by climate change, leading to higher exposure and infection rates. Tick-borne illnesses contribute to the demand for Lyme disease testing by serving as the primary mode of transmission for Lyme disease, necessitating early detection and diagnosis to manage rising infection cases effectively. For instance, in July 2024, according to the Centers for Disease Control and Prevention, a US-based federal public health agency, 71,346 cases of tick-borne disease were reported in 2022, an increase from 36,177 cases in 2021. Therefore, the rising prevalence of tick-borne illnesses is driving the growth of the lyme disease testing industry.

Who Are The Major Players In The Global Lyme Disease Testing Market?

Major companies operating in the lyme disease testing market are Roche Holding AG, Thermo Fisher Scientific Inc., Labcorp Holdings Inc., Quest Diagnostics Incorporated, Eurofins Scientific, BIOMÉRIEUX, Quidel Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A, Meridian Bioscience, Everlywell, Trinity Biotech, T2 Biosystems, IGeneX, Viramed Biotech AG, Ceres Nanosciences, Galaxy Diagnostics, Novatein Biosciences, Lyme Diagnostics Ltd

What Are The Key Trends Of The Global Lyme Disease Testing Market? Technological Advancements In Diagnostic Tools For Enhanced Accuracy And Early Detection Capabilities

Major companies operating in the Lyme disease testing market are focusing on technological advancements in diagnostic tools to enhance test accuracy, reduce turnaround times, and enable early-stage detection of the disease. Diagnostic tools refer to medical devices, kits, or technologies used to detect the presence of Lyme disease by identifying specific antibodies, antigens, or genetic material associated with the Borrelia burgdorferi bacteria. For instance, in August 2024, EpitogenX Ltd., a UK-based biotechnology company, announced the launch of a cutting-edge Lyme Disease Diagnostic Kit. It is an ELISA-based assay crafted using their proprietary EpitoGen platform. It features ~120 distinct Borrelia epitopes, offering high specificity and sensitivity, and is tailored for research use (RUO). It supports early, strain-specific detection and can be customized for different laboratory applications. Designed for research and diagnostic labs, it's ideal for improving detection accuracy and enabling deeper insights into Lyme disease.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Lyme Disease Testing Market? T2 Biosystems Partners With ECO Laboratory To Advance Early Lyme Disease Detection In The U.S.

In May 2024, T2 Biosystems Inc., a US-based in vitro diagnostics (IVD) company, partnered with ECO Laboratory to enhance Lyme disease diagnostics. This partnership aims to accelerate the development and clinical validation of the T2Lyme Panel, a molecular diagnostic test designed for the early and accurate detection of Lyme disease. The collaboration leverages ECO Laboratory's CLIA-certified infrastructure to expand access to advanced tick-borne disease testing across the U.S. ECO Laboratory is a US-based company, a specialized diagnostic service provider in the lyme and tick-borne disease space.

What Is The Regional Outlook For The Global Lyme Disease Testing Market?

North America was the largest region in the acute care telemedicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Acute Care Telemedicine Market?

The acute care telemedicine market includes revenues earned by entities by providing services like virtual emergency care, remote intensive care unit monitoring, tele-stroke evaluations, virtual hospitalist support, and real-time specialist consultations. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Lyme Disease Testing Industry?

The lyme disease testing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including lyme disease testing industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the lyme disease testing industry. The lyme disease testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Author : Abdul Wasay

Lyme Disease Testing Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$10.68 billion
Revenue Forecast In 2034	$15.11 billion
Growth Rate	CAGR of 9.1% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	Test Type, Testing Methodology, Disease Stage, Sample Type, End-User, Serological Tests, Nucleic Acid Tests, Urine Antigen Tests, Other Test Types
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Roche Holding AG, Thermo Fisher Scientific Inc., Labcorp Holdings Inc., Quest Diagnostics Incorporated, Eurofins Scientific, BIOMÉRIEUX, Quidel Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A, Meridian Bioscience, Everlywell, Trinity Biotech, T2 Biosystems, IGeneX, Viramed Biotech AG, Ceres Nanosciences, Galaxy Diagnostics, Novatein Biosciences, Lyme Diagnostics Ltd
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Lyme Disease Testing Market Characteristics

3. Lyme Disease Testing Market Trends And Strategies

4. Lyme Disease Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Lyme Disease Testing Growth Analysis And Strategic Analysis Framework

5.1. Global Lyme Disease Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Lyme Disease Testing Market Growth Rate Analysis

5.4. Global Lyme Disease Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Lyme Disease Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Lyme Disease Testing Total Addressable Market (TAM)

6. Lyme Disease Testing Market Segmentation

6.1. Global Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Serological Tests

Nucleic Acid Tests

Urine Antigen Tests

Other Test Types

6.2. Global Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Enzyme-Linked Immunosorbent Assay (ELISA)

Weste Blot

Polymerase Chain Reaction (PCR)

Immunofluorescence Assay (IFA)

Other Emerging Technologies

6.3. Global Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Early Lyme Disease

Disseminated Lyme Disease

Chronic Lyme Disease

Asymptomatic Lyme Disease Detection

6.4. Global Lyme Disease Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Blood

Urine

Cerebrospinal Fluid(CSF)

Other Blood Samples

6.5. Global Lyme Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals And Clinics

Diagnostic Laboratories

Home Care Settings

Research Institutions

Public Health Organizations

6.6. Global Lyme Disease Testing Market, Sub-Segmentation Of Serological Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Enzyme-Linked Immunosorbent Assay

Western Blot

Immunofluorescence Assay (IFA)

Line Immunoassay (LIA)

6.7. Global Lyme Disease Testing Market, Sub-Segmentation Of Nucleic Acid Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Polymerase Chain Reaction (PCR)

Loop-Mediated Isothermal Amplification (LAMP)

Next-Generation Sequencing (NGS)

6.8. Global Lyme Disease Testing Market, Sub-Segmentation Of Urine Antigen Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Lateral Flow Assay

Enzyme Immunoassay (EIA)

Immunoblot Urine Tests

6.9. Global Lyme Disease Testing Market, Sub-Segmentation Of Other Test Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Culture-Based Tests

Tick-Borne Co-Infection Panels

Artificial Intelligence-Assisted Diagnostic Tools

7. Lyme Disease Testing Market Regional And Country Analysis

7.1. Global Lyme Disease Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Lyme Disease Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Lyme Disease Testing Market

8.1. Asia-Pacific Lyme Disease Testing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Lyme Disease Testing Market

9.1. China Lyme Disease Testing Market Overview

9.2. China Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Lyme Disease Testing Market

10.1. India Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Lyme Disease Testing Market

11.1. Japan Lyme Disease Testing Market Overview

11.2. Japan Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Lyme Disease Testing Market

12.1. Australia Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Lyme Disease Testing Market

13.1. Indonesia Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Lyme Disease Testing Market

14.1. South Korea Lyme Disease Testing Market Overview

14.2. South Korea Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Lyme Disease Testing Market

15.1. Western Europe Lyme Disease Testing Market Overview

15.2. Western Europe Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Lyme Disease Testing Market

16.1. UK Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Lyme Disease Testing Market

17.1. Germany Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Lyme Disease Testing Market

18.1. France Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Lyme Disease Testing Market

19.1. Italy Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Lyme Disease Testing Market

20.1. Spain Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Lyme Disease Testing Market

21.1. Eastern Europe Lyme Disease Testing Market Overview

21.2. Eastern Europe Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Lyme Disease Testing Market

22.1. Russia Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Lyme Disease Testing Market

23.1. North America Lyme Disease Testing Market Overview

23.2. North America Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Lyme Disease Testing Market

24.1. USA Lyme Disease Testing Market Overview

24.2. USA Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Lyme Disease Testing Market

25.1. Canada Lyme Disease Testing Market Overview

25.2. Canada Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Lyme Disease Testing Market

26.1. South America Lyme Disease Testing Market Overview

26.2. South America Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Lyme Disease Testing Market

27.1. Brazil Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Lyme Disease Testing Market

28.1. Middle East Lyme Disease Testing Market Overview

28.2. Middle East Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Lyme Disease Testing Market

29.1. Africa Lyme Disease Testing Market Overview

29.2. Africa Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Lyme Disease Testing Market Competitive Landscape And Company Profiles

30.1. Lyme Disease Testing Market Competitive Landscape

30.2. Lyme Disease Testing Market Company Profiles

30.2.1. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Labcorp Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Eurofins Scientific Overview, Products and Services, Strategy and Financial Analysis

31. Lyme Disease Testing Market Other Major And Innovative Companies

31.1. BIOMÉRIEUX

31.2. Quidel Corporation

31.3. Bio-Rad Laboratories Inc.

31.4. QIAGEN N.V.

31.5. DiaSorin S.p.A

31.6. Meridian Bioscience

31.7. Everlywell

31.8. Trinity Biotech

31.9. T2 Biosystems

31.10. IGeneX

31.11. Viramed Biotech AG

31.12. Ceres Nanosciences

31.13. Galaxy Diagnostics

31.14. Novatein Biosciences

31.15. Lyme Diagnostics Ltd.

32. Global Lyme Disease Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Lyme Disease Testing Market

34. Recent Developments In The Lyme Disease Testing Market

35. Lyme Disease Testing Market High Potential Countries, Segments and Strategies

35.1 Lyme Disease Testing Market In 2029 - Countries Offering Most New Opportunities

35.2 Lyme Disease Testing Market In 2029 - Segments Offering Most New Opportunities

35.3 Lyme Disease Testing Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Lyme Disease Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Lyme Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Lyme Disease Testing Market, Sub-Segmentation Of Serological Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Lyme Disease Testing Market, Sub-Segmentation Of Nucleic Acid Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Lyme Disease Testing Market, Sub-Segmentation Of Urine Antigen Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Lyme Disease Testing Market, Sub-Segmentation Of Other Test Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Lyme Disease Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Global Lyme Disease Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: Asia-Pacific, Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: China, Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: India, Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Japan, Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Australia, Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Indonesia, Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: South Korea, Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: Western Europe, Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: UK, Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: Germany, Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: France, Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Italy, Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Spain, Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Eastern Europe, Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Russia, Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: North America, Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: USA, Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: Canada, Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: South America, Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Brazil, Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Middle East, Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Africa, Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 80: Roche Holding AG Financial Performance

Table 81: Thermo Fisher Scientific Inc. Financial Performance

Table 82: Labcorp Holdings Inc. Financial Performance

Table 83: Quest Diagnostics Incorporated Financial Performance

Table 84: Eurofins Scientific Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Lyme Disease Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Lyme Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Lyme Disease Testing Market, Sub-Segmentation Of Serological Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Lyme Disease Testing Market, Sub-Segmentation Of Nucleic Acid Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Lyme Disease Testing Market, Sub-Segmentation Of Urine Antigen Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Lyme Disease Testing Market, Sub-Segmentation Of Other Test Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Lyme Disease Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Global Lyme Disease Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: Asia-Pacific, Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: China, Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: India, Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Japan, Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Australia, Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Indonesia, Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: South Korea, Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: Western Europe, Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: UK, Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: Germany, Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: France, Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Italy, Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Spain, Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Eastern Europe, Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Russia, Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: North America, Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: USA, Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: Canada, Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: South America, Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Brazil, Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Middle East, Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Africa, Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 80: Roche Holding AG Financial Performance

Figure 81: Thermo Fisher Scientific Inc. Financial Performance

Figure 82: Labcorp Holdings Inc. Financial Performance

Figure 83: Quest Diagnostics Incorporated Financial Performance

Figure 84: Eurofins Scientific Financial Performance

In-Depth Aerosol Drug Delivery Devices Market Report: Business Trends, Growth Factors, and Forecast to 2029

2025 Analysis: Opportunities and Risks in the Evolving Ambulance Stretchers Market

Industry Forecast: Antimicrobial Resistance Diagnostics Market to Generate $5.82 Billion Revenue by 2029

Emerging Trends and Growth Drivers in the Artificial Intelligence (AI) In Endoscopy Market Through 2029

Discover the latest insights, trends, and market numbers in the maternal and baby grade wipes market backed by expert analysis and data-driven projections.

Discover the latest insights, trends, and market numbers in the medical soap market backed by expert analysis and data-driven projections.

Discover the latest insights, trends, and market numbers in the lichen planus market backed by expert analysis and data-driven projections.

Discover the latest insights, trends, and market numbers in the medical syringe drive systems market backed by expert analysis and data-driven projections.

Biologics Testing Global Market Report 2025 – By Product (Reagents And Kits, Instruments, Other Products), By Test Type (Endotoxin Test, Sterility Test, Mycoplasma Tests, Bioburden Tests, Residual Host-Cell Proteins And ...

COVID-19 Saliva Screening Test Potential Global Market Report 2025 – By Location (Travel Stations, Sports Arenas, Entertainment Venues, Corporate Campus Environments, Universities And Colleges, Factories, Other Locations...

Typhoid Antibody Testing Global Market Report 2025 – By Product Type (Rapid Serological Tests, Hem-agglutination And Co-agglutination, Counter Immunoelectrophoresis, Typhidot Test, Widal Test), By Paratyphi Type (Paratyp...

Chlamydia Infection Diagnostics Global Market Report 2025 – By Test Type (Culture Test, Nucleic Acid Amplification Test (NAAT), Direct Fluorescent Antibody Test, Serology Test, Other Test Types), By Type Of Infections (G...

Clinical Diagnostics Global Market Report 2025 – By Test (Lab Test, Imaging Test, Other Tests), By Product (Instruments, Reagents, Other Products), By End User (Hospital Laboratory, Diagnostic Laboratory, Point-Of-Care T...

Minimal Residual Disease Testing Global Market Report 2025 – By Test Type (DNA - Based Test, RNA- Based Test, Immunological Test), By Technology (Flow Cytometry, Polymerase Chain Reaction (PCR), Next-Generation Sequencin...

Bleeding Disorder Testing Global Market Report 2025 – By Product Type (Reagents And Consumables, Instruments), By Indication (Hemophilia A, Hemophilia B, Von Willebrand Disease, Idiopathic Thrombocytopenic Purpura, Other...

Frequently Asked Questions

What is the definition of the Lyme Disease Testing market?

How will the Lyme Disease Testing market drivers and restraints affect the market dynamics? What forces will shape the Lyme Disease Testing industry going forward?

The Lyme Disease Testing market major growth driver - Rising Prevalence Of Tick-Borne Illnesses Fueling The Need For Early Detection And Diagnosis. For further insights on the Lyme Disease Testing market, request a sample here

What is the forecast market size or the forecast market value of the Lyme Disease Testing market?

The Lyme Disease Testing market size has grown strongly in recent years. The lyme disease testing market size has grown strongly in recent years. It will grow from $9.77 billion in 2024 to $10.68 billion in 2025 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to increasing demand for early disease detection, growing availability of advanced diagnostic tools, rising incidence of tick populations due to climate change, increasing government funding for vector-borne disease control, and growing healthcare infrastructure in rural and endemic areas. The lyme disease testing market size is expected to see strong growth in the next few years. It will grow to $15.11 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to increasing travel to endemic regions, increasing use of multiplex diagnostic technologies, a rising number of outdoor recreational activities, growing demand for home-based testing kits, and rising concerns over co-infections with other tick-borne diseases. Major trends in the forecast period include advancements in molecular diagnostic techniques, advancements in biomarker research, technology innovation in point-of-care testing devices, developments in lab-on-a-chip (microfluidic) technology, and advancements in immunoassay technologies. For further insights on the Lyme Disease Testing market, request a sample here

How is the Lyme Disease Testing market segmented?

The lyme disease testing market covered in this report is segmented –
1) By Test Type: Serological Tests, Nucleic Acid Tests, Urine Antigen Tests, Other Test Types
2) By Testing Methodology: Enzyme-Linked Immunosorbent Assay (ELISA), Weste Blot, Polymerase Chain Reaction (PCR), Immunofluorescence Assay (IFA), Other Emerging Technologies
3) By Disease Stage: Early Lyme Disease, Disseminated Lyme Disease, Chronic Lyme Disease, Asymptomatic Lyme Disease Detection
4) By Sample Type: Blood, Urine, Cerebrospinal Fluid(CSF), Other Blood Samples
5) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Home Care Settings, Research Institutions, Public Health Organizations Subsegments:
1) By Serological Tests: Enzyme-Linked Immunosorbent Assay, Western Blot, Immunofluorescence Assay (IFA), Line Immunoassay (LIA)
2) By Nucleic Acid Tests: Polymerase Chain Reaction (PCR), Loop-Mediated Isothermal Amplification (LAMP), Next-Generation Sequencing (NGS)
3) By Urine Antigen Tests: Lateral Flow Assay, Enzyme Immunoassay (EIA), Immunoblot Urine Tests
4) By Other Test Types: Culture-Based Tests, Tick-Borne Co-Infection Panels, Artificial Intelligence-Assisted Diagnostic Tools For further insights on the Lyme Disease Testing market, request a sample here

Which region has the largest share of the Lyme Disease Testing market? What are the other regions covered in the report?

North America was the largest region in the lyme disease testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lyme disease testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Lyme Disease Testing market, request a sample here.

Who are the major players in the Lyme Disease Testing market?

What are the key trends in the Lyme Disease Testing market?

Major trends in the Lyme Disease Testing market include Technological Advancements In Diagnostic Tools For Enhanced Accuracy And Early Detection Capabilities. For further insights on the Lyme Disease Testing market, request a sample here.